Thomas Jay Lowery
Technik-/Wissenschafts-/F&E-Leiter bei Satellite Biosciences, Inc.
Aktive Positionen von Thomas Jay Lowery
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Satellite Biosciences, Inc.
Satellite Biosciences, Inc. BiotechnologyHealth Technology Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2020 | - |
Karriereverlauf von Thomas Jay Lowery
Ehemalige bekannte Positionen von Thomas Jay Lowery
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
T2 BIOSYSTEMS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2007 | - |
Ausbildung von Thomas Jay Lowery
University of California, Berkeley | Doctorate Degree |
Brigham Young University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
T2 BIOSYSTEMS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Satellite Biosciences, Inc.
Satellite Biosciences, Inc. BiotechnologyHealth Technology Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021. | Health Technology |
- Börse
- Insiders
- Thomas Jay Lowery
- Erfahrung